KTM
RMD icon

Keeler Thomas Management’s ResMed RMD Stock Holding History

Keeler Thomas Management’s Portfolio RMD Stock Details RMD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$2.34M Buy
12,000
+1,919
+19% +$398K 0.83% 35
2026
Q1 		$2.26M Buy
10,081
+4,725
+88% +$1.18M 0.96% 39
2025
Q4 		$1.29M Buy
5,356
+7
+0.1% +$1.79K 0.61% 54
2025
Q3 		$1.46M Buy
5,349
+70
+1% +$19.1K 0.6% 52
2025
Q2 		$1.36M Buy
+5,279
New +$1.26M 0.59% 52

Other funds holding RMD

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return
First Trust Advisors
First Trust Advisors Wheaton, Illinois $170B AUM 46.21% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return

Keeler Thomas Management's RMD Position: Q2 2026 in Review

Keeler Thomas Management increased its ResMed (RMD) stake by 19% in Q2 2026, buying an estimated $398K and bringing the position to 12,000 shares worth $2.34M. The position accounts for 0.83% of the portfolio, ranked #35.

Keeler Thomas Management first reported a position in RMD in Q2 2025 and has held it in 5 quarters since. 889 funds tracked by Wall St. Rank hold RMD as of Q2 2026.

  • Keeler Thomas Management held 12,000 shares of ResMed worth $2.34M as of Q2 2026.
  • Keeler Thomas Management bought 1,919 ResMed shares in Q2 2026, an estimated $398K.
  • ResMed made up 0.83% of Keeler Thomas Management's portfolio in Q2 2026, its #35 holding.
  • Keeler Thomas Management first reported a position in ResMed in Q2 2025 and has held it in 5 quarters since.
  • 889 funds tracked by Wall St. Rank held ResMed as of Q2 2026.

Based on Keeler Thomas Management's 13F filing for Q2 2026, filed 30 Jul 2026.